|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4745 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61K 31/65 | (2006.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3110843 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15755187.0 |
| Date of filing the European patent application | 2015-02-25 | |
| (97) | Date of publication of the European application | 2017-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-11 |
| (46) | Date of publication of the claims translation | 2019-11-11 |
| (86) | Number | PCT/US2015/017420 |
| Date | 2015-02-25 |
| (87) | Number | WO 2015/130728 |
| Date | 2015-09-03 |
| (30) | Number | Date | Country code |
| 201461946002 P | 2014-02-28 | US | |
| 201462006386 P | 2014-06-02 | US |
| (72) |
DOSHI, Parul, US
|
| (73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kombinacinės terapijos su anti-CD38 antikūnais |
| COMBINATION THERAPIES WITH ANTI-CD38 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-01-20 | 11 | 289.00 EUR |
| 2026-02-25 |